European Commission President Ursula von der Leyen declared on Tuesday a deal with Moderna for the supply of its coronavirus vaccine applicant of up to 160 million doses. She affirmed that this is the sixth such contract the European Union has settled with a pharmaceutical company and that another one is being negotiated, “setting up one of the most comprehensive COVID-19 portfolios in the world.”
Von der Leyen affirmed that all the vaccines will be assessed “very carefully” by the European Medicines Agency and “only authorized and placed on the market if they are safe and effective.” She also stressed the EU’s commitment to funding the distribution of coronavirus vaccines in low-income countries, including a donation of close to €800 million to the COVAX facility
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
